Can Taking a Test Now Tell You if You’ve Already Had COVID-19?

The Scientist asks Brigham and Women’s Hospital infectious disease specialist Lindsey Baden about testing for prior infections.

Written byNatalia Mesa, PhD
| 4 min read
Man in lab coat looking at camera and smiling
Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

In April of 2022, almost two and a half years into the pandemic, the Centers for Disease Control and Prevention estimated that 40 percent of the US population had yet to contract SARS-CoV-2, the virus that causes COVID-19. Thanks to the highly transmissible BA.5 variant, that percentage is probably smaller now, but there are still some people who don’t seem to have ever had an infection—or at least, they’ve never had symptoms or tested positive. SARS-CoV-2 infections can be totally asymptomatic, and the variant in question as well as other factors can influence testing accuracy, raising the possibility that a person could have had COVID-19 and not been aware of it. In addition to leaving many wondering whether they’ve actually caught the virus, this kind of uncertainty also causes headaches for epidemiologists, especially those who want to track community spread.

Generally, testing for prior infections involves looking for antibodies that ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • A black and white headshot

    As she was completing her graduate thesis on the neuroscience of vision, Natalia found that she loved to talk to other people about how science impacts them. This passion led Natalia to take up writing and science communication, and she has contributed to outlets including Scientific American and the Broad Institute. Natalia completed her PhD in neuroscience at the University of Washington and graduated from Cornell University with a bachelor’s degree in biological sciences. She was previously an intern at The Scientist, and currently freelances from her home in Seattle. 

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies